RedHill Biopharma (RDHL) Change in Inventory (2017 - 2022)

RedHill Biopharma (RDHL) has 6 years of Change in Inventory data on file, last reported at $1.6 million in Q4 2022.

• Change in Inventory for Q4 2022 came in at $1.6 million, up 192.87% year-over-year; the trailing twelve-month figure through Dec 2022 was $3.8 million (up 145.88% YoY), and the FY2025 annual result was -$375000.0, down 150.81% from the prior year.
• Change in Inventory improved to $1.6 million in Q4 2022 per RDHL's latest filing, from -$865000.0 in the prior quarter.
• Over five years, Change in Inventory peaked at $2.6 million in Q2 2022 and troughed at -$4.4 million in Q3 2021.
• A 5-year average of -$517850.0 and a median of -$325000.0 in 2018 frame the typical range for Change in Inventory.
• The sharpest annual moves came in 2020 and 2022: Change in Inventory tumbled 1905.06% in 2020, then surged 403.55% in 2022.
• A 5-year view of Change in Inventory shows it stood at -$300000.0 in 2018, then surged by 126.33% to $79000.0 in 2019, then plunged by 1905.06% to -$1.4 million in 2020, then fell by 18.93% to -$1.7 million in 2021, then soared by 192.87% to $1.6 million in 2022.
• Business Quant data shows RDHL's Change in Inventory at $1.6 million in Q4 2022, -$865000.0 in Q3 2022, and $2.6 million in Q2 2022.